Vanda Pharmaceuticals Inc. (VNDA): Shares Outstanding
59.10M
As of 2025-12-31
60.45M
As of 2026-06-30
+1.3%
3-year compound annual growth
+1.5%
5-year compound annual growth
+3.3%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 59.10M | +1.4% | 2026-02-12, Balance as of period end |
| 2024-12-31 | 58.31M | +1.3% | 2026-02-12, Balance as of period end |
| 2023-12-31 | 57.53M | +1.3% | 2025-02-14, Balance as of period end |
| 2022-12-31 | 56.78M | +1.6% | 2024-02-08, Balance as of period end |
| 2021-12-31 | 55.90M | +1.9% | 2023-02-09, Balance as of period end |
| 2020-12-31 | 54.87M | +2.5% | 2022-02-24, Balance as of period end |
| 2019-12-31 | 53.55M | +2.0% | 2021-02-11, Balance as of period end |
| 2018-12-31 | 52.48M | +16.8% | 2020-02-26, Balance as of period end |
| 2017-12-31 | 44.94M | +2.1% | 2019-02-19, Balance as of period end |
| 2016-12-31 | 44.00M | +2.8% | 2018-02-15, Balance as of period end |
| 2015-12-31 | 42.82M | +3.2% | 2017-02-17, Balance as of period end |
| 2014-12-31 | 41.49M | +24.4% | 2016-02-12, Balance as of period end |
| 2013-12-31 | 33.34M | +18.0% | 2015-03-13, Balance as of period end |
| 2012-12-31 | 28.24M | +0.4% | 2014-02-25, Balance as of period end |
| 2011-12-31 | 28.12M | +0.3% | 2013-02-26, Balance as of period end |
| 2010-12-31 | 28.04M | n/a | 2012-03-09, Balance as of period end |